About us

  1. ホーム
  3. About Us
  1. Top Message
  2. Company Profile
  3. Company History
  4. Sites
写真

Top Message

Creating value with the aim of "To be the best reliable API manufacturer".

写真

In 1946, Kyowa Pharma Chemical started a business in Takaoka, Toyama Prefecture. Since then, the company has been working on creating pharmaceutical production centered on our proprietary organic synthesis technology. Since 2007, as a subsidiary of Kyowa Hakko Bio Co. Ltd. of Kirin Group, Kyowa Pharma Chemical has been operating businesses in two domains: the pharmaceutical domain, where the company manufactures active pharmaceutical ingredients, and the health science domain (intermediate domain between Pharmaceuticals and Food & Beverages) that includes functional cosmetics. Also, from now on, we would like to realize our vision of "A leading API manufacturer in Japan” by focusing on the CDMO (Contract Development and Manufacturing Organization) business, which conducts contract manufacturing from the early stage of drug development.
Kirin Group has selected four key issues: "Health and Well-Being," "Community Engagement," "The Environment," and "A Responsible Alcohol Producer" as its initiatives to solve social issues and has compiled guidelines for each issue. We are working towards realizing the guideline for "Health and Well-Being" in particular. As a company whose core business is the manufacture of active pharmaceutical ingredients (APIs), we recognize that our business, which is delivering high-quality pharmaceuticals that support patients’ lives to our customers around the world, is an opportunity to achieve social and economic value.
We are planning to start the full operation of a pilot plant in the near future. The pilot plant will enable us to expand our opportunities to deliver our products to even more customers worldwide, starting with the CDMO business, which we will strengthen.
Kyowa Pharma Chemical will continue to strive "To be the best reliable API manufacturer" needed by customers, patients, and local communities to "nurture a healthier world and more smiles.”

Hayato Miyoshi, President & CEO

Company Profile

【Company Information】

Name
KYOWA PHARMA CHEMICAL CO., LTD.
Founded
October 1, 1946
Incorporated
December 29, 1951
Capital
6,276 million yen
Stockholder
KYOWA HAKKO BIO CO., LTD.(100%)
Employees
399（as of January 1,2024）
President
Hayato Miyoshi
Corporate Activities
Manufacture, Sale, Export, and Import of:
Active Pharmaceutical Ingredients, Diagnostics, Food Additives,
Feed Additives, Cosmetic Ingredients, and Fine Chemicals.

【Executives and Corporate Officers, etc.】

Representative Director, President & CEO
Hayato Miyoshi
Director
Nobuaki Kajio
Vice President ＆ COO
Takashi Suda
Managing Corporate Officer
Makoto Nishimura
Corporate Officer
Yasuhiro Hayakawa
Corporate Officer
Masako Hamano
Corporate Officer
Yuki Takeuchi
Auditor
Tomohiro Kaneko

Company History

1946
Founded Fuji Pharmaceutical Co., Ltd.
1974
Capital and Technical Alliance with Daiichi Pharmaceutical Co., Ltd. (Currently: Daiichi Sankyo Co., Ltd.)
2001
Company name changed to Daiichi Fine Chemical Co., Ltd.
2007
Became a subsidiary of Kyowa Hakko Kogyo Co., Ltd. (currently Kyowa Kirin Co., Ltd.)
2015
Company name changed to Kyowa Pharma Chemical Co., Ltd.
2019
Changed from a subsidiary of Kyowa Hakko Kirin Co., Ltd. (currently Kyowa Kirin Co., Ltd.)
to a subsidiary of Kirin Holdings Co., Ltd.

Sites

【Head Office/Factory】

530 Chokeiji, Takaoka, Toyama 933-8511, Japan MAP

【Tokyo Office】

NAKANO CENTRAL PARK SOUTH
10-2, Nakano 4-chome, Nakano-ku,
Tokyo 164-0001, Japan MAP